Ingrid A. Holm, MD, MPH, FACMG, FAAP is Professor of Pediatrics at Harvard Medical School (HMS), faculty in the Division of Genetics and Genomics and the Division of Endocrinology at Boston Children's Hospital (BCH), and teaching faculty at the HMS Center for Bioethics. She received her MD at the University of California, Los Angeles (UCLA) and completed her residency in pediatrics and joint fellowships in Genetics and Endocrinology at BCH. In 2003 she completed the Harvard Pediatric Health Services Research Fellowship and received her MPH in Clinical Effectiveness at the Harvard School of Public Health. In 2018 she received a certificate in Pediatric Bioethics from Children's Mercy Center for Bioethics.

Dr. Holm's primary area of research is the Ethical, Legal, and Social Implications (ELSI) of genomics. She is co-PI with Dr. Robert Green (BWH) of the NCATS-funded "Implementation of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy Infants"(BabySeq2) that explores the medical, behavioral, and economic impacts of integrating genomic sequencing into the care of newborns of diverse backgrounds. Since 2012 Dr. Holm has been a member of the NHGRI-funded Electronic Medical Records and Genomics (eMERGE) Network, leading ELSI projects in the return of genomic information to participants and providers. As a pediatric geneticist, Dr. Holm's other interest is in rare disease research. She is Associate Director of Robert's Program in Sudden Unexpected Death in Pediatrics (SUDP), which takes an innovative approach to SUDP as a group of rare diseases. She is a member of the Undiagnosed Diseases Network Harvard Clinical site. She is co-PI of an NHGRI R01 "Providing ethical guidance for the development of individualized genomic medicines as rare as n-of-1". Dr. Holm is Chair of the BCH IRB; she is also a member of the All of Us (Precision Medicine Initiative) Research Program IRB.